JP2009534292A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534292A5
JP2009534292A5 JP2008544698A JP2008544698A JP2009534292A5 JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5 JP 2008544698 A JP2008544698 A JP 2008544698A JP 2008544698 A JP2008544698 A JP 2008544698A JP 2009534292 A5 JP2009534292 A5 JP 2009534292A5
Authority
JP
Japan
Prior art keywords
moisture
measured
results
conditions
stored
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008544698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2007/059428 external-priority patent/WO2007126135A1/en
Publication of JP2009534292A publication Critical patent/JP2009534292A/ja
Publication of JP2009534292A5 publication Critical patent/JP2009534292A5/ja
Abandoned legal-status Critical Current

Links

JP2008544698A 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンｉｉ拮抗薬の医薬組成物 Abandoned JP2009534292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79517906P 2006-04-27 2006-04-27
PCT/JP2007/059428 WO2007126135A1 (en) 2006-04-27 2007-04-26 Pharmaceutical composition of angiotensin ii antagonists with pioglitazone hcl

Publications (2)

Publication Number Publication Date
JP2009534292A JP2009534292A (ja) 2009-09-24
JP2009534292A5 true JP2009534292A5 (th) 2010-04-30

Family

ID=38328300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544698A Abandoned JP2009534292A (ja) 2006-04-27 2007-04-26 塩酸ピオグリタゾンを有するアンジオテンシンｉｉ拮抗薬の医薬組成物

Country Status (6)

Country Link
JP (1) JP2009534292A (th)
AR (1) AR060663A1 (th)
CL (1) CL2007001195A1 (th)
PE (1) PE20080696A1 (th)
TW (1) TW200800299A (th)
WO (1) WO2007126135A1 (th)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
EP2164474A2 (en) * 2007-05-08 2010-03-24 Dow Global Technologies Inc. Water dispersible polymer compositions
AU2012326976B2 (en) 2011-10-21 2017-08-17 Takeda Pharmaceutical Company Limited Sustained-release preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW284688B (th) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
CA2456034A1 (en) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Sustained-release medicines
KR20070073872A (ko) * 2004-10-07 2007-07-10 다케다 야쿠힌 고교 가부시키가이샤 대사 증후군의 예방 또는 치료용 제제

Similar Documents

Publication Publication Date Title
JP2012031147A5 (th)
SA112330957B1 (ar) تركيبات لإيقاف النزف
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
EA201190092A1 (ru) Композиции с отсроченным высвобождением для перорального применения, содержащие аморфный бардоксолон метил (cddo-me)
UA108105C2 (ru) Азотсодержащие гетероарильные соединения
MX2010005087A (es) Formulacion solida de liberacion rapida, preparacion y uso de la misma.
JP2012031131A5 (th)
JP2010242999A5 (th)
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
JP2012158592A5 (th)
MX2010003001A (es) Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
CO6440564A2 (es) Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona
JP2009534292A5 (th)
EP2343065A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING FELULIC ACID AND MATRINE COMPOUNDS, PREPARATION AND USE THEREOF
JP2014024874A5 (th)
HU0900376D0 (en) Nanoparticulate candesartan cilexetil composition, process for the preparation thereof and pharmaceutical compositions containing them
WO2012052169A3 (de) Partikelförmige pharmazeutische zusammensetzung mit einem opioid und einem opioid-antagonisten
BR112014030160A2 (pt) composição formadora de película, uso de uma composição formadora de película, película e cápsula dura
IL206657A (en) Transformed oxindole derivatives, the pharmaceutical compositions containing them and their use in the preparation of drugs for the treatment of vasopressin-dependent diseases
EP2497464A3 (en) Pharmaceutical composition of imatinibe methanesulphonate and a process for its manufacture
PT2389070E (pt) Formulações desintegráveis de carbonato de lantânio
TR201007250A2 (tr) Selobioz içeren formülasyon.
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
RS53359B (en) COMPOSITION OF THE FERIMANITOL OVALBUMIN TABLET